COLL · Collegium Pharmaceutical, Inc · Documents
$23.75
+0.84 (+3.64%)
At close · Oct 22
Return incl. dividend (before tax)
Market Cap
$746.01M
Shares
32.56M
Volume · Oct 22
252.19K
Avg daily vol (3M)
781.51K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| SC TO-T | — | 2022-02-18 | — | |
| 8-K | — | 2022-02-14 | — | |
| SC TO-C | — | 2022-02-14 | — | |
| 8-K | — | 2021-12-28 | — | |
| 8-K | — | 2021-11-12 | — | |
| 10-Q | — | 2021-11-04 | 2021-09-30 | |
| 8-K | — | 2021-11-04 | — | |
| 8-K | — | 2021-09-30 | 2021-09-24 | |
| 8-K | — | 2021-08-16 | — | |
| 8-K | — | 2021-08-05 | — | |
| 10-Q | — | 2021-08-05 | 2021-06-30 | |
| 8-K | — | 2021-06-02 | — | |
| 8-K | — | 2021-05-24 | 2021-05-20 | |
| 10-Q | — | 2021-05-06 | 2021-03-31 | |
| 8-K | — | 2021-05-06 | — | |
| DEF 14A | — | 2021-04-07 | 2021-05-20 | |
| DEFA14A | — | 2021-04-07 | — | |
| 8-K | — | 2021-02-25 | — | |
| 10-K | — | 2021-02-25 | 2020-12-31 | |
| 8-K | — | 2021-01-06 | — | |
| 8-K | — | 2020-12-30 | 2020-12-27 | |
| 10-Q | — | 2020-11-05 | 2020-09-30 | |
| 8-K | — | 2020-11-05 | — | |
| 8-K | — | 2020-09-30 | 2020-09-29 | |
| 8-K | — | 2020-09-25 | 2020-09-24 | |
| 8-K | — | 2020-08-05 | — | |
| 10-Q | — | 2020-08-05 | 2020-06-30 | |
| 8-K | — | 2020-07-09 | 2020-07-08 | |
| 8-K | — | 2020-05-22 | 2020-05-20 | |
| 10-Q | — | 2020-05-07 | 2020-03-31 | |
| 8-K | — | 2020-05-07 | — | |
| DEF 14A | — | 2020-04-09 | 2020-05-20 | |
| DEFA14A | — | 2020-04-09 | — | |
| PRE 14A | — | 2020-03-25 | 2020-05-20 | |
| S-3 | — | 2020-03-16 | — | |
| 10-K | — | 2020-02-27 | 2019-12-31 | |
| 8-K | — | 2020-02-27 | — | |
| 8-K | — | 2020-02-13 | 2020-02-10 | |
| 8-K | — | 2020-02-10 | 2020-02-06 | |
| 8-K | — | 2020-02-06 | — | |
| 8-K | — | 2020-01-07 | — |
Showing 101–141 of 141 filings
Key facts
CIK
1267565
CUSIP
19459J104
13F (30d)
22 filings
22 filers
Visit website
Investor relations